How does receptor discordance in metastatic breast cancer impact overall survival rates?
Receptor discordance in metastatic breast cancer is linked to worse overall survival, especially when hormone receptors are lost.
Read the full answer →What does a pilot study say about deep longitudinal profiling for metastatic cancer patients?
The provided sources do not contain any pilot study on deep longitudinal profiling for metastatic cancer patients.
Read the full answer →Does having different receptors in metastatic breast cancer lesions affect how long I live?
Yes, different receptor types in metastatic breast cancer lesions are linked to different survival times, with hormone receptor-positive subtypes generally having longer survival than HER2-positive or triple-negative subtypes.
Read the full answer →What immune checkpoint inhibitor is best for survival in metastatic cervical cancer?
Pembrolizumab plus chemotherapy is the best-supported immune checkpoint inhibitor for improving overall survival in metastatic cervical cancer, especially in PD-L1 positive patients.
Read the full answer →Does the neutrophil-to-lymphocyte ratio predict progression-free survival in metastatic cervical cancer patients?
A high neutrophil-to-lymphocyte ratio (NLR) before treatment predicts shorter progression-free survival in metastatic cervical cancer patients receiving immunotherapy, while a low ratio suggests better outcomes.
Read the full answer →How does the neutrophil-to-lymphocyte ratio predict survival in metastatic cervical cancer treated with immune therapy?
A lower neutrophil-to-lymphocyte ratio (NLR) before starting immune therapy predicts longer survival and better response rates in metastatic cervical cancer, while a higher ratio signals a worse outlook.
Read the full answer →What evidence exists for liver cancer alongside lung, breast, and kidney cancer?
Research shows liver cancer detection using liquid biopsies has high accuracy similar to lung, breast, and kidney cancers, while survival rates for liver cancer have improved significantly in recent years.
Read the full answer →Can machine learning with cfDNA help detect liver cancer at different stages?
Yes, machine learning with cfDNA can detect liver cancer at various stages, with sensitivities ranging from 44% for stage I to 99% for stage III and high specificity.
Read the full answer →Can single-port surgery be used as an alternative technique for localized prostate cancer?
Yes, single-port surgery is a safe and feasible alternative for localized prostate cancer, with benefits like less blood loss and same-day discharge, but may have a learning curve and lower early continence rates.
Read the full answer →Does radical perineal prostatectomy cause less blood loss than the retropubic approach for localized prostate cancer?
Yes, radical perineal prostatectomy typically causes less blood loss than the retropubic approach for localized prostate cancer, based on direct comparative studies.
Read the full answer →What is the survival benefit of central vascular ligation in colon cancer?
Central vascular ligation (CVL) during complete mesocolic excision improves disease-free and overall survival in colon cancer, but the benefit may be limited to certain tumor stages and comes with higher perioperative risk.
Read the full answer →Does having a high-fat diet increase my risk for colon cancer?
Research shows that a high-fat diet can increase the risk of colon cancer by changing gut bacteria and damaging cells, though doctors also consider other factors like age and smoking when assessing risk.
Read the full answer →Does low vitamin D before diagnosis increase the risk of getting thyroid cancer?
Yes, pre-diagnostic vitamin D deficiency is linked to a higher risk of developing thyroid cancer, based on a large retrospective cohort study.
Read the full answer →Can taking levothyroxine help suppress TSH levels after thyroid cancer surgery?
Yes, levothyroxine is used after thyroid cancer surgery to suppress TSH, which helps reduce the risk of cancer recurrence.
Read the full answer →What specific radiomic features does the new MRI model use to stratify risk?
The new MRI model uses intratumoral habitat heterogeneity features (from K-means clustering) and peritumoral radiomic features from 1, 2, and 3 mm margins around the tumor.
Read the full answer →Can structured rehabilitation before surgery reduce pneumonia risk for esophageal cancer patients?
Yes, structured rehabilitation before surgery can reduce pneumonia risk for esophageal cancer patients, especially when it includes multiple components like exercise and nutrition.
Read the full answer →Does waiting longer before surgery after radiation improve quality of life for esophageal cancer?
Waiting 10-12 weeks (vs. 4-6 weeks) after chemoradiation before surgery improves preoperative quality of life for esophageal cancer patients, with similar long-term outcomes.
Read the full answer →Can a blood test accurately detect oral cancer based on recent research?
Blood tests for oral cancer are not yet accurate enough for routine screening; recent research shows promising but variable results, with some methods achieving ~95% accuracy in small studies.
Read the full answer →What is the average chance of getting delirium if I have advanced cancer?
Based on a meta-analysis of 17 studies, the average chance of delirium in advanced cancer is about 36% (roughly 1 in 3 patients).
Read the full answer →Will doing mindful breathing four times a day help my symptom scores?
Yes, a 2020 trial found that four daily mindful breathing sessions significantly reduced total ESAS symptom scores in advanced cancer patients compared to standard care alone.
Read the full answer →Can telehealth visits improve my quality of life while I have advanced cancer?
Yes, telehealth visits can improve quality of life for advanced cancer patients, with studies showing significant benefits in symptom management and care access.
Read the full answer →Is deep longitudinal profiling available for patients with metastatic colorectal cancer?
Yes, deep longitudinal profiling is available for metastatic colorectal cancer patients through research studies like the High-Definition Oncology (HDO) pilot, which collects multi-modal data over time.
Read the full answer →Can a nomogram predict complications after surgery for my metastatic colorectal cancer?
Yes, a nomogram can predict moderate-to-severe complications after primary tumor resection in metastatic colorectal cancer, using factors like age and tumor size.
Read the full answer →How can artificial intelligence help diagnose bladder cancer alongside prostate and kidney cancers?
AI helps diagnose bladder, prostate, and kidney cancers by combining imaging, pathology, and genetic data for more accurate detection and risk assessment.
Read the full answer →